ESR1 and breast carcinoma: Other studies show that in certain cancer lines (e.g., MCF-7) and in certain ERα-negative breast cancers (the molecular apocrine subtype) AR can successfully mimic the cistrome of ER and be pro-proliferative, as it is antiproliferative in luminal breast cancers.